Latent Tuberculosis Infection Clinical Trial
Official title:
Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits
The overall objective of this study is to assess the feasibility and potential impact of using a targeted testing approach and 2 interferon-gamma release assays (IGRA) to screen for latent tuberculosis (TB) infection (LTBI) among military recruits. The current policy of universal application of the Mantoux tuberculin skin test (TST) to screen for LTBI may result in many TST reactions among recruits who are at low risk for LTBI. The central hypothesis is that targeted testing by use of the questionnaire will reduce unnecessary testing of low-risk recruits without affecting the identification of higher-risk recruits. The secondary hypothesis is that many discordant results between the TST and IGRA may be explained by cross-reactivity to non-tuberculous mycobacteria (NTM) with the TST.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04094012 -
Risk of SDRs Under 3HP and 1HP Regimen for LTBI
|
Phase 3 | |
| Completed |
NCT01582711 -
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
|
Phase 3 | |
| Recruiting |
NCT06033807 -
Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
|
||
| Completed |
NCT01622140 -
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
|
||
| Completed |
NCT00557765 -
Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area
|
N/A | |
| Completed |
NCT00463086 -
Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
|
N/A | |
| Active, not recruiting |
NCT01398618 -
Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
|
Phase 3 | |
| Recruiting |
NCT00905970 -
Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection
|
N/A | |
| Recruiting |
NCT00449345 -
Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis
|
N/A | |
| Completed |
NCT02641106 -
VDOT for Monitoring Adherence to LTBI Treatment
|
N/A | |
| Completed |
NCT01136161 -
Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
|
Phase 2 | |
| Recruiting |
NCT03312647 -
Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection
|
N/A | |
| Completed |
NCT02810678 -
Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment
|
N/A | |
| Completed |
NCT01223534 -
QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
|
Phase 4 | |
| Withdrawn |
NCT00558480 -
Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis
|
N/A | |
| Recruiting |
NCT00692809 -
Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
|
N/A | |
| Completed |
NCT03702049 -
Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIV
|
N/A | |
| Terminated |
NCT01761201 -
"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".
|
Phase 3 | |
| Completed |
NCT01608685 -
Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients
|
N/A | |
| Completed |
NCT01007396 -
Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay
|
N/A |